Compare

Illumina vs IQVIA

MonkScore ranges and fundamentals, side by side

Key facts

Illumina and IQVIA: key facts

  • In fiscal 2025, Illumina, Inc. reported revenue of $4.3B and net income of $850.0M.
  • In fiscal 2025, IQVIA Holdings Inc. reported revenue of $16.3B and net income of $1.4B.
  • Illumina, Inc.'s revenue fell 1.1% a year from fiscal 2021 to fiscal 2025.
  • IQVIA Holdings Inc.'s revenue grew 4.1% a year from fiscal 2021 to fiscal 2025.
  • Illumina, Inc.'s free cash flow was positive in 5 of the 5 fiscal years from 2021 to 2025.
  • IQVIA Holdings Inc.'s free cash flow was positive in 5 of the 5 fiscal years from 2021 to 2025.
  • In the twelve months to 27 September 2026, Illumina, Inc. reported revenue of $4.5B and net income of $895.0M.
  • In the twelve months to 30 September 2026, IQVIA Holdings Inc. reported revenue of $17.3B and net income of $1.4B.

Side by side

Illumina and IQVIA, side by side

Each figure is in the company's reporting currency, with its fiscal year or the date of its last report.

FigureIllumina, Inc.NASDAQ:ILMNIQVIA Holdings Inc.NYSE:IQV
MonkScore
MonkScore range90–100as of October 202670–80as of October 2026
Sector rank33 of 628 in Healthcare153 of 628 in Healthcare
How this score is madeDisclaimer
Profile
SectorHealthcareHealthcare
IndustryMedical - Diagnostics & ResearchMedical - Diagnostics & Research
Latest fiscal year
Revenue$4.3BFY 2025$16.3BFY 2025
Net income$850.0MFY 2025$1.4BFY 2025
Free cash flow$931.0MFY 2025$2.1BFY 2025
Operating cash flow$1.1BFY 2025$2.7BFY 2025
Total debt$2.6BFY 2025$16.2BFY 2025
Cash$1.4BFY 2025$2.0BFY 2025
Last 12 months
Revenue$4.5Bto 27 September 2026$17.3Bto 30 September 2026
Net income$895.0Mto 27 September 2026$1.4Bto 30 September 2026
Free cash flow$1.1Bto 27 September 2026$2.1Bto 30 September 2026
Operating cash flow$1.2Bto 27 September 2026$2.7Bto 30 September 2026
Total debt$2.2Bto 27 September 2026$16.3Bto 30 September 2026
Cash$1.3Bto 27 September 2026$2.2Bto 30 September 2026

MonkStreet provides research, not investment advice.